Roman Necina

Vice President & General Manager, Viral Vectors

Cytiva

Roman Necina is Vice President & General Manager, Viral Vectors at Cytiva, where he leads the company's viral vector business and collaborates with customers and industry partners to advance manufacturing strategies that support the development, scale-up, and commercialization of gene therapies. With a broad perspective across the viral vector market, Roman works closely with technology, manufacturing, and industry leaders to address the challenges facing the next generation of gene therapies.

From clinical safety signals to manufacturing innovation: Advancing AAV quality
Tuesday, October 27, 2026
As AAV programs progress into larger clinical studies and commercial manufacturing, decisions made early in development can have far-reaching consequences for product safety, process robustness, and regulatory readiness. This webinar explores emerging scientific and regulatory perspectives on AAV quality, including the FDA Advanced Manufacturing Technology (AMT) designation, impurity control, and how cell-line engineering, process development, and manufacturing strategy can work together to strengthen product safety from the start.